Park, H.J.; Zheng H.; Kulkarni D.; Kerrigan J.; Pungaliya P.; Saleem A.; Rubin E.H."Identification of phosphorylation sites of TOPORS and a role for serine 98 in the regulation of ubiquitin but not SUMO E3 ligase activity." Biochemistry 2008, 47(52), 13887-96.

Kerrigan, JE; Ragunath, C; Kandra, L; Gyemant, G; Liptak, A; Janossy, L; Kaplan, JB; Ramasubbu, NR “Modeling and Biochemical Analysis of the Activity of Antibiofilm Agent Dispersin B” Acta Biologica Hungarica 2008, 59(4), 439-451

Lyu, YL; Kerrigan, JE; Azarova, AM; Tsai, YC; Ban, Y.; Liu, LF “Topoisomerase II{b} Mediated DNA Double-Strand Breaks: Implications in Doxorubicin Cardiotoxicity and Prevention by Dexrazoxane.” Cancer Res. 2007, 67(18), 8839-46.

Vaidyanathan, J.; Vaidyanathan, T.K.; Kerrigan, J.E. "Evaluation of intermolecular interactions of self-etch dentin adhesive primer molecules with type 1 collagen: Computer modeling and in vitro binding analysis." Acta Biomater. 2007, 3(5), 705-714.

Perez, L; Kerrigan, J.E.; Li, X.; Fan, H. "Substitution of Met435 with leucine, isoleucine, or serine in tumor necrosis factor alpha converting enzyme inactivates ectodomain shedding activity." Biochem. Cell Biol. 2007, 85, 141-149.

Lin, W.; Bernard, M.P.; Cao, D.; Myers, R.V.; Kerrigan, J.E.; Moyle, W.R. "Follitropin Receptors Contain Cryptic Ligand Binding Sites" Mol. Cell. Endocrinol. 2007, 260-262, 83-92 .

Minhas, G.; Pilch, D.S.; Kerrigan, J.E.; LaVoie, E.J.; Rice, J.R. "Synthesis and G-Quadruplex Stabilizing Properties of a Series of Oxazole-Containing Macrocycles" Bioorg. Med. Chem. Lett. 2006, 16, 3891-3895.

Moyle, W.R.; Lin, W.; Myers, R.V.; Cao, D.; Kerrigan, J.E.; Bernard, M.P. "Models of glycoprotein hormone receptor interaction." Endocrine, 2005, 26(3), 189-205.

Moyle, W.R.; Xing, Y.; Lin, W.; Cao, D.; Myers, R.V.; Kerrigan, J.E.; Bernard, M.P. "Model of Glycoprotein Hormone Receptor Ligand Binding and Signaling" J. Biol. Chem., 2004, 279(43), 44442-44459.

Wu, W.; Kerrigan, J.E.; Yadav, P.; Schwartz, B.; Izotova, L.; Lavoie, T.; Pestka, S. "Design and Construction of a Phosphorylatable Chimeric Monoclonal Antibody with a Highly Stable Phosphate" Oncology Research, 2004, 14 (11/12), 541-558.

Kerrigan, J.E.; Pilch, D.S.; Ruchelman, A.L.; Zhou, N.; Liu, A.; Liu, L.; LaVoie, E.J. “5H-8,9-Dimethoxy-5(2-N,N-dimethylaminoethyl)dibenzol[c,h][1,6]naphthyridin-6-ones and Related Compounds as TOP1-Targeting Agents: Influence of Structure on the Ternary Cleavable Complex Formation” Bioorg. Med. Chem. Lett. 2003, 13(20), 3395-3399.

Kerrigan, J.E.; Vagnoni, L.M. “Effect of the amino versus the acylamino substituent on the product isomer distribution in the methanolysis of 5-(substituted)amino-2-[(methylsulfonyl)oxy]isoindole-1,3-diones.” Tetrahedron 2001, 57, 8227-8235.

Kerrigan, J.E.; Pilch, D.S. "A Structural Model for the Ternary Cleavable Complex Formed Between Human Topoisomerase I, DNA, and Camptothecin." Biochemistry 2001, 40, 9792-9798.

Vagnoni, L.M.; Gronostaj, M; Kerrigan, J.E. “6-Acylamino-2-[(ethylsulfonyl)oxy]-1H-isoindole-1,3-dione Mechanism-Based Inhibitors of Human Leukocyte Elastase and Cathepsin G. Effect of Chirality in the 6-Acylamino Substituent on Inhibitory Potency and Selectivity.” Bioorg. Med. Chem. 2001, 9(3), 637-645.

Kerrigan, J.E.; Walters, M.C.; Forrester, K.J.; Crowder, J.B.; Christopher, L.J. “6-Acylamino-2-[(alkylsulfonyl)oxy]-1-H-isoindole-1,3-dione Mechanism-Based Inhibitors of Human Leukocyte Elastase” Bioorg. Med. Chem. Lett. 2000, 10, 27-30.